Free Trial

Girish Satya Sells 41,662 Shares of Zevia PBC (NYSE:ZVIA) Stock

Zevia PBC logo with Consumer Staples background
Image from MarketBeat Media, LLC.

Key Points

  • Insider sale: Zevia CFO Girish Satya sold 41,662 shares on March 25 at an average price of $1.18 for about $49,161, cutting his stake by 11.27% to 327,909 shares; the sale was disclosed in an SEC filing.
  • Weak financials and low share price: ZVIA trades around $1.13 (1‑year range $1.11–$3.66) with a market cap of $84.5M, negative EPS and margins, and analysts expect roughly -$0.32 EPS for the fiscal year.
  • Mixed analyst and institutional activity: The stock has an average "Hold" rating with a $4.43 target, while institutional investors hold 53.21% of shares and several funds recently increased or initiated positions.
  • MarketBeat previews the top five stocks to own by May 1st.

Zevia PBC (NYSE:ZVIA - Get Free Report) CFO Girish Satya sold 41,662 shares of the firm's stock in a transaction on Wednesday, March 25th. The stock was sold at an average price of $1.18, for a total value of $49,161.16. Following the completion of the sale, the chief financial officer directly owned 327,909 shares of the company's stock, valued at $386,932.62. This represents a 11.27% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Zevia PBC Price Performance

Shares of ZVIA opened at $1.13 on Friday. Zevia PBC has a 1 year low of $1.11 and a 1 year high of $3.66. The stock's fifty day moving average price is $1.55 and its two-hundred day moving average price is $2.11. The firm has a market cap of $84.49 million, a PE ratio of -7.50 and a beta of 0.90.

Zevia PBC (NYSE:ZVIA - Get Free Report) last posted its quarterly earnings results on Wednesday, February 25th. The company reported ($0.02) earnings per share for the quarter, topping the consensus estimate of ($0.03) by $0.01. Zevia PBC had a negative return on equity of 22.49% and a negative net margin of 6.15%.The company had revenue of $37.87 million during the quarter, compared to the consensus estimate of $39.96 million. Sell-side analysts anticipate that Zevia PBC will post -0.32 earnings per share for the current fiscal year.

Institutional Trading of Zevia PBC

A number of hedge funds and other institutional investors have recently made changes to their positions in ZVIA. Bank of America Corp DE boosted its stake in Zevia PBC by 2,845.4% in the 4th quarter. Bank of America Corp DE now owns 15,817 shares of the company's stock worth $66,000 after purchasing an additional 15,280 shares during the period. Cubist Systematic Strategies LLC grew its holdings in Zevia PBC by 52.7% during the 1st quarter. Cubist Systematic Strategies LLC now owns 79,275 shares of the company's stock valued at $171,000 after buying an additional 27,343 shares in the last quarter. Dynamic Technology Lab Private Ltd bought a new stake in shares of Zevia PBC during the first quarter valued at about $187,000. Geode Capital Management LLC lifted its holdings in shares of Zevia PBC by 66.5% in the second quarter. Geode Capital Management LLC now owns 933,407 shares of the company's stock worth $3,006,000 after buying an additional 372,665 shares in the last quarter. Finally, Police & Firemen s Retirement System of New Jersey purchased a new stake in shares of Zevia PBC in the second quarter worth about $25,000. 53.21% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on the stock. Craig Hallum assumed coverage on shares of Zevia PBC in a research report on Thursday, January 15th. They set a "buy" rating and a $4.00 target price for the company. Weiss Ratings restated a "sell (d-)" rating on shares of Zevia PBC in a research note on Wednesday, January 21st. Finally, Telsey Advisory Group cut their price objective on shares of Zevia PBC from $6.00 to $5.00 and set an "outperform" rating for the company in a report on Thursday, February 26th. Three investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Hold" and an average price target of $4.43.

Check Out Our Latest Stock Analysis on ZVIA

About Zevia PBC

(Get Free Report)

Zevia PBC, headquartered in Los Angeles, is a Public Benefit Corporation that produces zero-calorie, naturally sweetened beverages. Founded in 2007, the company went public through a merger with a special purpose acquisition company in March 2021. Zevia's mission centers on offering healthier drink alternatives by using stevia leaf extract and other plant-based ingredients rather than sugar or artificial sweeteners.

The company's product portfolio spans multiple categories, including carbonated sodas, sparkling water, energy drinks, mixers and flavored teas.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Zevia PBC Right Now?

Before you consider Zevia PBC, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zevia PBC wasn't on the list.

While Zevia PBC currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines